FBLG
FibroBiologics, Inc.
1.30$
-0.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 100.0% | 54.4% | 78.0% | 86.5% | 66.0% | |
| – | 87.0% | 47.0% | 77.5% | 85.0% | 50.9% | |
| – | 87.0% | 47.0% | 77.5% | 85.0% | 50.9% | |
| – | – | 6.2% | – | – | – | |
| – | 375.6% | 182.8% | 89.4% | 83.4% | 36.0% | |
| – | 375.6% | 146.6% | 77.7% | 77.4% | 18.3% | |
| – | 277.8% | 119.8% | 3.1% | 58.2% | 7.3% | |
| – | 49.8% | 15.7% | 12.2% | 16.4% | 9.8% | |
| – | -275.6% | -82.8% | 10.6% | 16.6% | 64.0% | |
| – | -587.8% | -163.2% | -206.0% | -216.0% | -563.1% | |
| – | 347.0% | 33.7% | 13.7% | 10.0% | 23.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.